Related Experiment Video
Updated: Jun 25, 2026
09:37
Defining Gene Functions in Tumorigenesis by Ex vivo Ablation of Floxed Alleles in Malignant Peripheral Nerve Sheath Tumor Cells
Published on: August 25, 2021
Modular protein engineering in emerging cancer therapies
Esther Vázquez1, Neus Ferrer-Miralles, Ramón Mangues
1Institut de Biotecnologia i de Biomedicina, Universitat Autònoma de Barcelona, 08193 Barcelona, Spain.
Current Pharmaceutical Design
|March 12, 2009
Summary
Targeted nanoconjugates offer personalized cancer treatments by delivering novel biopharmaceuticals. Recombinant proteins and peptides are key to engineering smart drug delivery vehicles for enhanced cancer therapies.
Area of Science:
- Biotechnology
- Nanomedicine
- Molecular Biology
Background:
- Growing demand for personalized treatments for cancer and genetic diseases.
- Limitations of conventional therapies necessitate innovative approaches.
- Nanoconjugates show promise for targeted drug delivery.
Purpose of the Study:
- To review the pharmacological applications of recombinant proteins in drug delivery.
- To explore methods for engineering functional polypeptides for targeted delivery.
- To discuss the potential of these constructs in novel cancer therapies.
Main Methods:
- Review of current literature on nanoconjugates and protein engineering.
- Discussion of recombinant DNA technologies for polypeptide design.
- Analysis of cancer biology for target identification.
Main Results:
- Proteins and peptides are suitable director moieties for nanoconjugates.
- Protein engineering enables the creation of multifunctional, modular drug vehicles.
- Targeted delivery systems can carry diverse biopharmaceuticals like DNA, RNA, and proteins.
Conclusions:
- Recombinant protein-based nanoconjugates represent a promising strategy for advanced cancer therapies.
- Engineering specific targeting moieties is crucial for therapeutic success.
- Understanding cancer molecular traits is essential for selecting optimal drug delivery targets.
Related Concept Videos
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
02:53Adaptive Mechanisms in Cancer Cells
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
02:53Adaptive Mechanisms in Cancer Cells
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
02:26Protein Networks
An organism can have thousands of different proteins, and these proteins must cooperate to ensure the health of an organism. Proteins bind to other proteins and form complexes to carry out their functions. Many proteins interact with multiple other proteins creating a complex network of protein interactions.
These interactions can be represented through maps depicting protein-protein interaction networks, represented as nodes and edges. Nodes are circles that are representative of a protein,...
These interactions can be represented through maps depicting protein-protein interaction networks, represented as nodes and edges. Nodes are circles that are representative of a protein,...
02:50Combination Therapies and Personalized Medicine
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...